ICICI Prudential Nifty Pharma Index Fund vs UTI Nifty 500 Value 50 Index Fund
ICICI Prudential Nifty Pharma Index Fund (Direct) and UTI Nifty 500 Value 50 Index Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Index Funds schemes — see the best index funds for the full ranking.
Head to head
NAVs as of 23 Oct 2026
Growth of ₹100 (rebased over the selected window)
Common period 12 May 2023 – 23 Oct 2026, limited by UTI Nifty 500 Value 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential Nifty Pharma Index Fund | UTI Nifty 500 Value 50 Index Fund | Nifty Pharma TRI | Nifty 500 Value 50 TRI |
|---|---|---|---|---|
| 12 May 2023 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 25 Aug 2023 | ₹119.86 | ₹114.21 | ₹120.66 | ₹115.71 |
| 08 Dec 2023 | ₹128.61 | ₹145.85 | ₹130.12 | ₹149.50 |
| 22 Mar 2024 | ₹149.73 | ₹171.94 | ₹151.80 | ₹177.81 |
| 05 Jul 2024 | ₹162.28 | ₹208.28 | ₹165.33 | ₹215.87 |
| 18 Oct 2024 | ₹185.54 | ₹206.05 | ₹189.11 | ₹215.23 |
| 31 Jan 2025 | ₹170.18 | ₹182.63 | ₹173.89 | ₹192.04 |
| 16 May 2025 | ₹172.04 | ₹193.48 | ₹175.80 | ₹204.98 |
| 29 Aug 2025 | ₹173.91 | ₹189.21 | ₹177.55 | ₹201.43 |
| 12 Dec 2025 | ₹181.74 | ₹208.95 | ₹186.10 | ₹223.89 |
| 27 Mar 2026 | ₹179.93 | ₹211.73 | ₹184.48 | ₹227.97 |
| 10 Jul 2026 | ₹204.84 | ₹225.23 | ₹210.31 | ₹244.28 |
| 23 Oct 2026 | ₹202.15 | ₹203.26 | ₹207.82 | ₹221.04 |
Portfolio overlap (same stocks held through more than one fund)
Some overlap is structural: SEBI defines large cap as the top 100 stocks by market capitalisation, so two large-cap funds are fishing the same pond by regulation. The bands below are measured per sleeve pairing rather than against one blanket threshold. How this is measured →
- 20 stocks only in ICICI Prudential Nifty Pharma Index Fund
- 0 stocks in both — 0.0% of each portfolio by weight
- 50 stocks only in UTI Nifty 500 Value 50 Index Fund
The more the circles overlap, the more the funds hold the same stocks.
ICICI Prudential Nifty Pharma Index Fund and UTI Nifty 500 Value 50 Index Fund share 0% of their equity book by weight.
| Metric | ICICI Prudential · Direct NAV ₹19.61 Very High risk ★★★★★ | UTI · Direct NAV ₹20.13 Very High risk ★★★★☆ | Category median Index Funds · 278 funds |
|---|---|---|---|
| +12.79%Best in row | -0.87% | -8.28% | |
| +19.38%Best in row | +19.08% | +8.96% | |
| +19.27% | +22.83% | +3.00% | |
| +21.93% | +25.65%Best in row | +15.34% | |
| Risk | |||
| 15.14%Best in row | 20.53% | 15.91% | |
| 0.85Best in row | 0.61 | 0.14 | |
| 1.22Best in row | 0.81 | 0.19 | |
| -16.59% | -22.63% | -18.65% | |
| Nifty Pharma TRI | Nifty 500 Value 50 TRI | — | |
| -0.67%Best in row | -2.09% | -0.70% | |
| 1.00 | 0.99 | 1.00 | |
| 99.2%Best in row | 95.8% | 98.5% | |
| 102.3%Best in row | 103.4% | 101.0% | |
| 0.51%Best in row | 0.73% | 0.48% | |
| ₹150.77Cr | ₹830.22Cr | ₹139.44Cr | |
| ₹1.00K | ₹500 | — | |
| 26% | 36% | 32% | |
| Nishit Patel | Ayush Jain | — | |
| 14 Dec 2022 | 10 May 2023 | — | |
| 20 | 50 | — | |
| 78.2% | 49.0% | — | |
| 0.1% | -0.2% | — | |
8 rows carry the same value for every fund — show
- 5Y return (CAGR)
- —
- 10Y return (CAGR)
- —
- 5Y SIP XIRR
- —
- 5Y rolling avg
- —
- 10Y rolling avg
- —
- Exit load
- None
- Lock-in
- None
- Min lumpsum
- ₹1.00K
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — ICICI Prudential Nifty Pharma Index Fund or UTI Nifty 500 Value 50 Index Fund?
Over the last 3 years, ICICI Prudential Nifty Pharma Index Fund returned +19.38% CAGR against UTI Nifty 500 Value 50 Index Fund's +19.08%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — ICICI Prudential Nifty Pharma Index Fund or UTI Nifty 500 Value 50 Index Fund?
ICICI Prudential Nifty Pharma Index Fund has the lower expense ratio: ICICI Prudential Nifty Pharma Index Fund charges 0.51% a year against UTI Nifty 500 Value 50 Index Fund's 0.73%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — ICICI Prudential Nifty Pharma Index Fund or UTI Nifty 500 Value 50 Index Fund?
UTI Nifty 500 Value 50 Index Fund has shown higher volatility (+20.53% annualized vs ICICI Prudential Nifty Pharma Index Fund's +15.14%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: ICICI Prudential Nifty Pharma Index Fund -16.59% vs UTI Nifty 500 Value 50 Index Fund -22.63%.
Which fund manages more money — ICICI Prudential Nifty Pharma Index Fund or UTI Nifty 500 Value 50 Index Fund?
UTI Nifty 500 Value 50 Index Fund is the larger fund: ICICI Prudential Nifty Pharma Index Fund manages ₹150.77Cr against UTI Nifty 500 Value 50 Index Fund's ₹830.22Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are ICICI Prudential Nifty Pharma Index Fund and UTI Nifty 500 Value 50 Index Fund in the same category?
Yes — both are Index Funds schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.